Legal Information

Intellectual Property Rights

The contents of this Web site are copyrighted. AstraZeneca Pharmaceuticals LP and AstraZeneca LP, members of the AstraZeneca group of companies (collectively, the "Company"), hereby authorize you to copy documents published on this Web site for non-commercial personal use only, provided that any copy of these documents which you make shall retain all copyright and other proprietary notices and any disclaimer contained on the documents. Except as expressly provided above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text or documents contained in this Web site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text or documents, without the express written consent of the Company.

No information or statement contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of the Company, or its affiliates, or any third party. Except as expressly provided above, no information or statement contained herein shall be construed as conferring any license or right under any AstraZeneca group patent, copyright or trademark.

All product names referred to herein are trademarks of the AstraZeneca group of companies, its licensors or joint venture partners unless otherwise indicated.

Disclaimers

The Company has undertaken reasonable efforts to include accurate and up-to-date information on its Web site. However, THIS WEB SITE IS PROVIDED "AS IS" AND THE COMPANY MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. THE COMPANY DOES NOT WARRANT THAT THE FUNCTIONS CONTAINED IN THE WEB SITE WILL BE UNINTERRUPTED OR ERROR FREE OR THAT THE WEB SITE OR THE SERVER THAT MAKES IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU. All users agree that all access and use of this Web site and its content is at their own risk.

Neither the Company nor any other party involved in creating, producing or delivering this Web site shall be liable in any manner for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Web site, or any errors or omissions in the content.

This Web site may provide links or references to other Internet sites maintained by third parties over whom the Company has no control. Such links are provided merely as a convenience to users of this Web site. The Company takes no responsibility for the content of such sites and makes no representations as to the accuracy or completeness of any information contained in such sites, and shall have no liability for any damages or injuries of any kind arising from such content or information.

Prescribing Information

Product information provided on this site is intended for use by U.S. residents only. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This information is available to the public for educational purposes only; it should not be used for diagnosing or treating a health problem or disease. It is not intended to substitute for consultation with a licensed healthcare provider. The Company cannot answer unsolicited emails requesting personal medical advice; please consult your healthcare provider.

Privacy Statement

Submissions

The Company welcomes inquiries and comments from visitors to this site. However, any communications or information sent by a visitor to a Company-sponsored Web site or to the Company by electronic mail, including questions, comments, data, ideas or know-how, shall be deemed to be non-confidential and shall become the property of the Company, without compensation to the provider of such submissions. The Company shall have no obligation of any kind with respect to such information and may reproduce, publish, disclose, and distribute to others all or any part of such information, without limitation, for any purpose whatsoever. The Company shall be free to use any ideas, concepts, know-how, techniques or inventions contained therein for any purpose, including but not limited to developing, manufacturing and marketing products and services.

Important Safety Information for Zomig
  • Do not take Zomig if you
    • Have heart disease or a history of heart disease
    • Have uncontrolled high blood pressure
    • Have hemiplegic or basilar migraine
    • Have or have had a stroke or symptoms of a stroke
    • Have or have had circulation (blood flow) problems
    • Have serious liver problems
    • Have taken other migraine medications in the last 24 hours, including other triptans, ergots, or ergot-type medications
    • Are taking monoamine oxidase (MAO) inhibitors, or if it has been less than 2 weeks since you stopped taking an MAO inhibitor
    • Are allergic to Zomig or any of its ingredients
    • Have symptomatic Wolff-Parkinson-White syndrome or other heart rhythm problems
    If you are not sure about any of the above, ask your doctor.
  • Tell your doctor about all the medicines you take or plan to take, including prescription and nonprescription medicines, supplements, and herbal remedies. Your doctor will decide if you can take Zomig with your other medicines
  • In very rare cases, patients taking Zomig may experience serious side effects such as heart attacks, increases in blood pressure, stroke, life-threatening disturbances of heart rhythm, constriction of blood vessels in the abdomen or other parts of the body, or serious allergic reactions. In extremely rare cases, patients have died from these side effects. Call your doctor right away if you have any of the following problems after taking Zomig: severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw that is severe or does not go away; shortness of breath or wheezing; sudden or severe stomach pain; bloody diarrhea; hives; tongue, mouth, lip, or throat swelling; problems seeing; slurring of speech; or unusual weakness or numbness
  • Tell your doctor if you have any risk factors for heart disease such as high blood pressure, high cholesterol, diabetes, smoking, being overweight, menopause, male over age 40, or a family history of heart disease or stroke. If you have risk factors and your evaluation for heart disease is satisfactory, your doctor may ask you to take the first dose of Zomig in the doctor's office
  • Some people who take Zomig may have a reaction called serotonin syndrome which can be life-threatening. In particular this reaction may occur when Zomig is used together with certain types of antidepressants known as SSRIs or SNRIs. Symptoms may include mental changes (confusion, hallucinations, agitation, coma), fast heartbeat, changes in blood pressure, feeling faint, fever, sweating, muscle spasm, trouble walking, nausea, vomiting, and/or diarrhea. Call your doctor immediately if you have any of these symptoms after taking Zomig
  • Phenylketonurics: Zomig-ZMT® (zolmitriptan) Orally Disintegrating Tablets contain phenylalanine, a component of the artificial sweetener aspartame
  • Tell your doctor if you are pregnant, planning to become pregnant, could be pregnant, are not using effective birth control, are breast feeding, or planning to breast feed because Zomig may not be right for you
  • The safety and effectiveness of Zomig have not been established in patients under 18 years of age or patients over 65 years of age
  • The most common side effects reported by patients in clinical trials for Zomig Tablets and Zomig-ZMT Orally Disintegrating Tablets include tingling sensation; weakness; nausea; dizziness; pain, tightness, pressure or heaviness such as in the chest, throat, neck, or jaw; drowsiness; and warm sensation. The most common side effects reported by patients in clinical studies for Zomig Nasal Spray include unusual taste; tingling sensation; skin sensitivity; dizziness; nausea; pain, pressure, and tightness sensations such as in the nose, throat, or chest; drowsiness; weakness; disorder/discomfort of the nasal cavity; and dry mouth
Approved Use for Zomig

Zomig is a prescription medicine approved to treat migraine headaches in adults. Only your doctor can determine if Zomig is right for you.

Zomig should only be used where a clear diagnosis of migraine has been established. For a given migraine attack, if you do not respond to the first dose of Zomig, then your doctor will need to determine if you really have a migraine headache before you take a second dose. Zomig is not for the prevention of migraines or for the treatment of hemiplegic or basilar migraines (if you are not sure about this, ask your doctor). Zomig is not for other types of headaches, including cluster headache.

This is not a complete summary of safety information. Please discuss the full Prescribing Information with your doctor.

Click here to see the full Prescribing Information for Zomig Tablets and Zomig-ZMT Orally Disintegrating TabletsOpens in new window (PDF — 194KB)

Click here to see the full Prescribing Information for Zomig Nasal SprayOpens in new window (PDF — 122KB)

Click here to see Important Zomig Product Information for PatientsOpens in new window (PDF — 480KB)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.